NCBA Group PLC (NASE:NCBA)
65.00
+0.25 (0.39%)
At close: Aug 7, 2025
Ligand Pharmaceuticals Market Cap
NCBA Group has a market cap or net worth of 107.09 billion as of August 8, 2025. Its market cap has increased by 59.12% in one year.
Market Cap
107.09B
Enterprise Value
n/a
Revenue
58.30B
Ranking
n/a
PE Ratio
4.86
Stock Price
$65.00
Market Cap Chart
Since September 30, 2019, NCBA Group's market cap has increased from 21.08B to 107.09B, an increase of 407.94%. That is a compound annual growth rate of 31.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 107.09B | 34.85% |
Dec 31, 2024 | 79.41B | 23.75% |
Dec 29, 2023 | 64.17B | -1.02% |
Dec 30, 2022 | 64.83B | 56.15% |
Dec 31, 2021 | 41.52B | -5.79% |
Dec 31, 2020 | 44.07B | -20.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Safaricom | 1,041.70B |
Equity Group Holdings | 194.34B |
East African Breweries | 164.20B |
KCB Group | 152.64B |
Standard Chartered Bank Kenya | 120.06B |
Absa Bank Kenya | 106.73B |
The Co-operative Bank of Kenya | 97.10B |
Stanbic Holdings | 71.06B |